Surgery Partners (NASDAQ:SGRY) Stock Rating Lowered by TD Cowen

Surgery Partners (NASDAQ:SGRY) was downgraded by TD Cowen from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks reports.

Several other equities analysts also recently issued reports on the company. Stonex Financia downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Benchmark restated a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Raymond James Financial set a $23.50 target price on Surgery Partners in a research note on Monday, October 26th. UBS Group cut Surgery Partners from a “buy” rating to a “hold” rating and increased their price target for the stock from $21.00 to $23.50 in a research note on Wednesday, October 28th. Finally, Royal Bank Of Canada lowered Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 price target on the stock. in a report on Monday, October 26th. Three research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $20.14.

Surgery Partners Trading Down 0.4%

Shares of NASDAQ:SGRY opened at $23.12 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. The company’s 50-day moving average price is $15.30 and its 200 day moving average price is $14.68. The company has a market cap of $3.03 billion, a PE ratio of -33.03, a P/E/G ratio of 7.19 and a beta of 1.90. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $23.37.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The firm had revenue of $848.90 million during the quarter, compared to analysts’ expectations of $830.03 million. During the same quarter in the prior year, the firm earned $0.17 EPS. Surgery Partners’s quarterly revenue was up 2.7% on a year-over-year basis. Sell-side analysts anticipate that Surgery Partners will post 0.25 earnings per share for the current year.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was acquired at an average price of $14.35 per share, with a total value of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares of the company’s stock, valued at $959,197.05. This represents a 17.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Surgery Partners

A number of institutional investors and hedge funds have recently bought and sold shares of SGRY. Jupiter Topco LLC acquired a new position in shares of Surgery Partners in the second quarter worth about $233,220,000. Pentwater Capital Management LP purchased a new position in shares of Surgery Partners in the second quarter worth approximately $195,384,000. BlackRock Inc. acquired a new stake in shares of Surgery Partners during the second quarter valued at approximately $104,857,000. Dimensional Fund Advisors LP raised its holdings in shares of Surgery Partners by 7.9% during the first quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock valued at $63,131,000 after acquiring an additional 389,831 shares during the period. Finally, Hsbc Holdings PLC acquired a new stake in shares of Surgery Partners during the second quarter valued at approximately $48,912,000.

Surgery Partners News Roundup

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Bon Secours Mercy Health’s proposed $23.50-per-share acquisition provides a clear valuation reference and supports the share price. Bain Capital, Surgery Partners’ largest shareholder, plans to roll its equity into the combined company, signaling substantial shareholder participation. Surgery Partners stock enters take-private focus after HealthSpan deal
• Neutral Sentiment: The consensus price target was raised 15.45% to $22.61, reflecting improved valuation expectations, but the target is below the merger offer and therefore provides limited incremental support while the transaction remains pending. Surgery Partners consensus price target increased by 15.45% to $22.61
• Negative Sentiment: KeyCorp reduced its FY2026 EPS forecast to $0.07 from $0.16 and cut its FY2027 forecast to a $0.21-per-share loss from expected earnings of $0.13. It also lowered its Q3 2026 estimate to a $0.13 loss, while forecasting a $0.08 loss for Q4. These revisions point to weaker near-term profitability than previously expected.
• Negative Sentiment: Multiple law firms are investigating the $23.50 merger, including whether Surgery Partners’ directors breached fiduciary duties and whether the transaction adequately serves shareholders. Such investigations may increase deal uncertainty, although these notices do not by themselves indicate that wrongdoing occurred. SGRY shareholder merger investigation Scott+Scott Surgery Partners investor alert

About Surgery Partners

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.